Last quarter (Q3 2023), Eloxx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eloxx Pharmaceuticals's net income was $-3.59M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expenses	$ 34.42M	$ 66.02M	$ 29.44M	$ 50.55M	$ 46.97M
Depreciation and Amortization	$ 695.00K	$ 960.00K	$ 571.00K	$ 559.00K	$ 216.00K
EBITDA	$ -31.75M	$ -64.51M	$ -32.60M	$ -48.70M	$ -46.15M
Operating Income	$ -34.42M	$ -66.02M	$ -33.45M	$ -50.55M	$ -47.56M
Other Income/Expenses	$ -1.65M	$ -709.00K	$ -1.12M	$ -319.00K	$ 502.00K
Pretax Income	$ -36.06M	$ -66.73M	$ -34.58M	$ -50.87M	$ -47.06M
Net Income	$ -36.06M	$ -66.73M	$ -34.58M	$ -50.87M	$ -47.19M
Per Share Metrics
Basic EPS	$ -16.65	$ -38.15	$ -34.47	$ -53.46	$ -58.19
Diluted EPS	$ -16.65	$ -38.15	$ -34.47	$ -53.46	$ -58.19
Weighted Average Shares Outstanding	2.17M	1.75M	1.00M	951.58K	810.91K
Weighted Average Shares Outstanding (Diluted)	2.17M	1.75M	1.00M	951.58K	810.91K

Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing